Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis AgfiledCriticalNovartis Ag
Priority claimed from EP11740973.0Aexternal-prioritypatent/EP2595960B1/en
Publication of RS54789B1publicationCriticalpatent/RS54789B1/sr
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Plural Heterocyclic Compounds
(AREA)
Abstract
Natrijumova so (S) -2- (difenilacetil) -1,2,3,4-tetrahidro-6-metoksi-5- (fenilmetoksi) -3- izohinolin karboksilne kiseline i njenih solvata, u amorfnom obliku ili u obliku kristalnog solvata.Prijava sadrži još 17 patentnih zahteva.
RS20160358A2010-07-212011-07-21Soli i solvati derivata tetrahidroizohinolina
RS54789B1
(sr)
4-(8-metoxi-1-((1-metoxipropan-2-il)-2-(tetrahidro-2h-piran-4-il)-1h-imidazo[4,5-c]quinolin-7-il)-3,5-dimetilisoxazol y su uso como inhibidor bromodominio
Pharmaceutical preparation containing 1– (4– (4– (4,3-dichloro-2 – fluorophenylamino) –7 – methoxyquinazoline – 6 – Iloxy) piperidine – 1 – il) Prof. 2 – an – 1 – on or a common pharmaceutical salt His and an acidic addition
Compuestos derivados de bencil sulfonamida, inhibidores de mogat-2; compuesto cristalino; composicion farmaceutica; y su uso en el tratamiento de la hipertrigliceridemia.